MLC-R

Germany
|
2022-2027
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition

StressLoC

Austria
|
2023-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition

Ballmann

Germany
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition

Azevedo

Portugal
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition

SENSING-AI

Spain
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition

SubFSC19-KN

Germany
|
2021-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Long-termAPP

France
|
2024-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition

LOCOMOTION

United Kingdom
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • Primary care
  • Telemedicine
  • SARS-CoV-2
  • Post COVID-19 condition

MEADOWSPRING

Argentina Belgium Brazil Denmark Germany Mexico Romania Switzerland Turkiye Ukraine
|
2021-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

McCracken

United Kingdom
|
2024-2026
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Blood sample

MINIRICO

Norway
|
2023-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Dietary
  • Psychotherapy

Fuensalida Novo

Spain
|
2024-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Rehabilitation
  • Stimulation